These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 2875320)
1. Transmissibility of human immunodeficiency virus in haemophilic and non-haemophilic children living in a private school in France. Berthier A; Chamaret S; Fauchet R; Fonlupt J; Genetet N; Gueguen M; Pommereuil M; Ruffault A; Montagnier L Lancet; 1986 Sep; 2(8507):598-601. PubMed ID: 2875320 [TBL] [Abstract][Full Text] [Related]
2. [HTLV-III antibodies and immunologic changes in hemophilic children. Prevalence of HTLV-III antibodies in hemophilic children and their relatives living in the same household]. Zenz W; Muntean W; Teubl I; Beaufort F; Heinz FX Padiatr Padol; 1987; 22(1):33-41. PubMed ID: 3108827 [TBL] [Abstract][Full Text] [Related]
3. Effects of exposure to factor concentrates containing donations from identified AIDS patients. A matched cohort study. Jason J; Holman RC; Dixon G; Lawrence DN; Bozeman LH; Chorba TL; Tregillus L; Evatt BL JAMA; 1986 Oct; 256(13):1758-62. PubMed ID: 3018305 [TBL] [Abstract][Full Text] [Related]
4. Correlation of antibodies to LAV/HTLV III in hemophiliacs with the use of virus-inactivated clotting factors. Dietz B; Klose HJ; Gürtler L; Eberle J; Deinhardt F; Köhler-Vajta K; Peller P Thromb Haemost; 1986 Aug; 56(1):50-2. PubMed ID: 3095947 [TBL] [Abstract][Full Text] [Related]
5. HTLV-I antibody status in hemophilia patients treated with factor concentrates prepared from U.S. plasma sources and in hemophilia patients with AIDS. Chorba TL; Jason JM; Ramsey RB; Lechner K; Pabinger-Fasching I; Kalyanaraman VS; McDougal JS; Cabradilla CD; Tregillus LC; Lawrence DN Thromb Haemost; 1985 Apr; 53(2):180-2. PubMed ID: 2992112 [TBL] [Abstract][Full Text] [Related]
6. No evidence for vertical transmission in children born to HIV seropositive male haemophiliacs. Berntorp E; Schulman S; Nilsson IM Scand J Infect Dis; 1988; 20(2):141-3. PubMed ID: 3165200 [TBL] [Abstract][Full Text] [Related]
7. HIV infection in Norwegian haemophiliacs: the prevalence of antibodies against HIV in haemophiliacs treated with lyophilized cryoprecipitate from volunteer donors. Evensen SA; Ulstrup J; Skaug K; Frøland SS; Glomstein A; Rollag H Eur J Haematol; 1987 Jul; 39(1):44-8. PubMed ID: 3115823 [TBL] [Abstract][Full Text] [Related]
8. Effect of using safer blood products on prevalence of HIV infection in haemophilic Canadians. Canadian Hemophilia Clinic Directors Group. BMJ; 1993 Jan; 306(6873):306-7. PubMed ID: 8461649 [No Abstract] [Full Text] [Related]
9. Prevalence of human immunodeficiency virus (HIV) infection among hemophiliacs in Fukuoka, Japan. Kashiwagi S; Hayashi J; Ikematsu H; Noguchi A; Ikeda K; Kishida K; Shirakawa M; Takenaka A; Mori R Microbiol Immunol; 1988; 32(8):851-5. PubMed ID: 3143898 [TBL] [Abstract][Full Text] [Related]
10. Natural history of acquired immunodeficiency syndrome in hemophilic patients. Kim HC; Nahum K; Raska K; Gocke DJ; Kosmin M; Karp GI; Saidi P Am J Hematol; 1987 Feb; 24(2):169-76. PubMed ID: 3101490 [TBL] [Abstract][Full Text] [Related]
11. HIV-related deaths in HIV antibody-positive haemophilic patients. Ragni MV; Kingsley LA; Kiss JE; Spero JA; Lewis JH Lancet; 1987 Jul; 2(8550):100. PubMed ID: 2885547 [No Abstract] [Full Text] [Related]
12. Prevalence and transmission of human immunodeficiency virus in Japan. Kurimura T; Kawatani T; Hattori N; Tsuchie H AIDS Res; 1986 Dec; 2 Suppl 1():S163-6. PubMed ID: 3103639 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus infection in multitransfused haemophiliacs. Nebbia G; Moroni GA; Simoni L; Belli M; Carnelli V Arch Dis Child; 1986 Jun; 61(6):580-4. PubMed ID: 3089179 [TBL] [Abstract][Full Text] [Related]
14. Factor VIII, HIV and AIDS in haemophiliacs: an analysis of their relationship. Papadopulos-Eleopulos E; Turner VF; Papadimitriou JM; Causer D Genetica; 1995; 95(1-3):25-50. PubMed ID: 7538088 [TBL] [Abstract][Full Text] [Related]
15. [Efficacy in viral inactivation of the concentrates of factor VIII and IX by the solvent/detergent procedure. Evaluation in patients with hemophilia]. Guerois C; Parquet A; Vicariot M; Lecoeur FF; Maisonneuve P; Courouce AM; Dubois F; Laurian Y Presse Med; 1991 Jun; 20(25):1163-6. PubMed ID: 1830653 [TBL] [Abstract][Full Text] [Related]
18. Clinical, immunological, and virological aspects in Japanese hemophiliacs and AIDS patients. Abe T AIDS Res; 1986 Dec; 2 Suppl 1():S141-6. PubMed ID: 3103637 [TBL] [Abstract][Full Text] [Related]
19. [Epidemiology of infection by LAV/HTLV-III virus in hemophiliacs multitransfused in France. Results of a survey conducted by 28 hemophilia centers]. Sultan Y Nouv Rev Fr Hematol (1978); 1986; 28(5):327-9. PubMed ID: 3643509 [TBL] [Abstract][Full Text] [Related]
20. Virus safety of pasteurized factor VIII and factor IX concentrates: study in virgin patients. Heimburger N; Karges HE; Weidmann E Dev Biol Stand; 1987; 67():303-10. PubMed ID: 3038638 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]